The FTC approved KKR's plan to buy Nashville, Tenn.-based Envision Healthcare Corp. July 19.
Here are four insights:
1. The deal is valued at $5.57 billion, Reuters reports. With debt included, the valuation is $9.9 billion.
2. KKR will pay about $46 per share if the transaction closes, according to an SEC filing. An Envision investor has attempted to block the sale with a class action complaint, claiming the price per share was too low.
3. Under the deal, Envision would become a privately owned company.
4. In a proxy statement, Envision Chairman William Sanger and President and CEO Christopher Holden encouraged shareholders to vote in favor of the proposal. The vote will take place at the 2018 annual meeting, no later than Oct. 1.
"The Envision board of directors has unanimously determined that the merger, the terms of the merger agreement and the other transactions contemplated by the merger agreement are advisable, fair to, and in the best interests of, Envision and its stockholders," the statement said.